6-Aminoquinoline → HCID 86685597, Verbindung
Reaktionsgleichung
Cl[C:2]1[N:7]=[C:6]([NH:8][C:9]2([C:13]([NH2:15])=[O:14])[CH2:12][CH2:11][CH2:10]2)[CH:5]=[N:4][C:3]=1[C:16]#[N:17].[NH2:18][C:19]1[CH:20]=[C:21]2[C:26](=[CH:27][CH:28]=1)[N:25]=[CH:24][CH:23]=[CH:22]2.C([O-])([O-])=O.[K+].[K+].C1C=CC(P(C2C(C3C(P(C4C=CC=CC=4)C4C=CC=CC=4)=CC=C4C=3C=CC=C4)=C3C(C=CC=C3)=CC=2)C2C=CC=CC=2)=CC=1>O1CCOCC1.CC([O-])=O.CC([O-])=O.[Pd+2]>[C:16]([C:3]1[N:4]=[CH:5][C:6]([NH:8][C:9]2([C:13]([NH2:15])=[O:14])[CH2:12][CH2:11][CH2:10]2)=[N:7][C:2]=1[NH:18][C:19]1[CH:20]=[C:21]2[C:26](=[CH:27][CH:28]=1)[N:25]=[CH:24][CH:23]=[CH:22]2)#[N:17]Komponenten
7
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
A mixture of 1-(6-chloro-5-cyanopyrazin-2-ylamino)cyclobutanecarboxamide (22 mg, 0.087 mmol), 6-aminoquinoline (30 mg, 0.208 mmol), K2CO3 (90 mg, 0.652 mmol), BINAP (25 mg, 0.040 mmol) and Pd(OAc)2 (15 mg, 0.066 mmol) in dioxane (2 mL) was degassed with Ar, then was stirred at 110 C for 5 h. The mixture was concentrated in vacuo. The residue was purified by HPLC to give 1-(5-cyano-6-(quinolin-6-ylamino)pyrazin-2-ylamino)cyclobutanecarboxamide (10 mg).
Aufarbeitung
- customwas degassed with Ar
- concentrationThe mixture was concentrated in vacuo
- customThe residue was purified by HPLC
Quellen und Nachweise
- ORD-Eintrag
- ord-602424a693d94763ac74910d67a546ef
- Quelldatensatz
- uspto-grants-2014_11
- Patentnummer
- US08877760B2
Notizen zur Reaktion
Wird geladen…